IFN-γ positive selected T-cells

BIOLOGICAL2 trials

Sponsors

University Hospital, Basel, Switzerland, Yae-Jean Kim

Conditions

Adenovirus InfectionAllogenic DiseaseCytokine Capture SystemCytomegalovirus InfectionsEBV

Phase 1

Adoptive Transfer of pp65-specific T Cells for the Treatment of Refractory Cytomegalovirus (CMV) Infection

WithdrawnNCT02346617

Yae-Jean KimCytomegalovirus Infections

Start: 2022-01-01End: 2024-12-01Updated: 2020-03-20

Phase 2

A Study to Assess Safety and Feasibility of Direct Infusions of Donor-derived Virus-specific T-cells in Recipients of Hematopoietic Stem Cell Transplantation With Post-transplant Viral Infections Using the Cytokine Capture System®

RecruitingNCT02007356

University Hospital, Basel, SwitzerlandAdenovirus Infection, Allogenic Disease, Cytokine Capture System +2

Start: 2014-12-31End: 2026-12-31Target: 30Updated: 2025-03-20